Hong Bok Sil
Cheju Halla University, Life Science Research Center, Department of Nursing, Jeju, Korea (the Republic of).
Int J Sports Med. 2022 May;43(5):455-465. doi: 10.1055/a-1678-7147. Epub 2021 Dec 6.
Physical activity and exercise can induce beneficial molecular and biological regulations that have been associated with an incidence of various diseases, including breast cancer. Recent studies demonstrated that the potential links between physical activity-induced circulating microRNAs (miRNAs) and cancer risk and progression. Here, we investigated whether altered miRNAs by exercise could influence breast cancer progression. After primary searching in PubMed and reviewing the full-text papers, candidate miRNAs altered by exercise in breast cancer were identified. Analysis of expression profiles and clinical outcomes of altered miRNAs using The Cancer Genome Atlas datasets showed altered miRNAs expressions were significantly associated with the patient's prognosis, whereas prognostic values of each miRNA varied in different stages and subtypes. In addition, altered miRNAs profiles regulated various target genes and key signaling pathways in tumorigenesis, including pathways in cancer and the PI3K-Akt signaling pathway; however, miRNAs regulated the expression of target genes differently according to tumor stages and subtypes. These results indicate that circulating miRNAs are promising noninvasive stable biomarkers for early detection, diagnosis, prognosis, and monitoring the response to clinical therapies of breast cancer. Moreover, stages and subtype-stratified approaches for breast cancer progression would be needed to evaluate the prognostic value of miRNAs for biomarkers and therapeutic targets.
体育活动和锻炼能够引发有益的分子和生物学调节,这些调节与包括乳腺癌在内的多种疾病的发生有关。最近的研究表明,体育活动诱导的循环微RNA(miRNA)与癌症风险及进展之间存在潜在联系。在此,我们研究了运动引起的miRNA改变是否会影响乳腺癌进展。在对PubMed进行初步检索并查阅全文论文后,确定了乳腺癌中因运动而改变的候选miRNA。使用癌症基因组图谱数据集对改变的miRNA的表达谱和临床结果进行分析,结果显示改变的miRNA表达与患者预后显著相关,而每种miRNA的预后价值在不同阶段和亚型中有所不同。此外,改变的miRNA谱在肿瘤发生过程中调节各种靶基因和关键信号通路,包括癌症相关通路和PI3K-Akt信号通路;然而,miRNA根据肿瘤阶段和亚型对靶基因表达的调节方式不同。这些结果表明,循环miRNA有望成为用于乳腺癌早期检测、诊断、预后评估以及监测临床治疗反应的非侵入性稳定生物标志物。此外,需要采用针对乳腺癌进展的阶段和亚型分层方法来评估miRNA作为生物标志物和治疗靶点的预后价值。